PRE 14A

PRELIMINARY PROXY STATEMENT

Company: RELMADA THERAPEUTICS, INC.
Filed: November 5, 2014
Period of Report: November 5, 2014
Accession Number: 0001213900-14-007760

View Document ↗ View on SEC.gov ↗